Chk2 activates E2F-1 in response to DNA damage

Nature Cell Biology

Volumn 5, Issue 5, 2003, Pages 401-409

  Stevens, Craig ^a   Smith, Linda ^a   La Thangue, Nicholas B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; ETOPOSIDE; MUTANT PROTEIN; PROTEIN KINASE; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL NUCLEUS; CONTROLLED STUDY; DNA DAMAGE; ENZYME ANALYSIS; HALF LIFE TIME; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; TUMOR CELL CULTURE;

APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL NUCLEUS; DNA DAMAGE; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; ETOPOSIDE; EUKARYOTIC CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NUCLEIC ACID SYNTHESIS INHIBITORS; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; SERINE; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0038752083     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb974     Document Type: Article

References (46)

1. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262 (1998).
2. Sherr, C. J. Cancer cell cycles. Science 274, 1672-1677 (1996).
3. Trimarchi, J. M. & Lees, J. A. Sibling rivalry in the E2F family. Nature Rev. Mol. Cell Biol. 3, 11-20 (2002).
4. Field, S. J. et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561 (1996).
5. Yamasaki, L. et al. Tumour induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-547 (1996).
6. Xu, G., Livingston, D. M. & Krek, W. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl Acad. Sci. USA 92, 357-1361 (1995).
7. Wu., L. et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414, 457-462 (2001).
8. Qin, X. Q., Livingston, D. M., Kaelin, W. G. Jr & Adams, P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl Acad. Sci. USA 91, 10918-10922 (1994).
9. Shan, B. & Lee, W. H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell Biol. 14, 8166-8173 (1994).
10. Wu, X. & Levine, A. J. P53 and E2F-1 co-operate to mediate apoptosis. Proc. Natl Acad. Sci. USA 91, 3602-3606 (1994).
11. DeGregori, J., Leone, G., Miron, A., Jakoi, L. & Nevins, J. R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl Acad. Sci. USA 94, 7245-7250 (1997).
12. Bates, S. et al. p14ARF links the tumour suppressor RB and p53. Nature 395, 124-125 (1998).
13. Sherr, C. J. Tumour surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984-2991 (1998).
14. Irwin, M. et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407, 645-648 (2000).
15. Lissy, N. A., Davis, P. K., Irwin, M., Kaelin, W. G. & Dowdy, S. F. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 407, 642-644 (2000).
16. Stiewe, T. & Putzer, B. M. Role of the p53 homologue p73 in E2F-1-induced apoptosis. Nature Genet. 26, 464-469 (2000).
17. Moroni, M. C. et al. Apaf-1 is a transcriptional target for E2F and p53. Nature Cell Biol. 3, 552-558 (2001).
18. Loughran, Ö. & La Thangue, N. B. Apoptotic and growth-promoting activity of E2F modulated by MDM2. Mol. Cell. Biol. 20, 2186-2197 (2000).
19. Blattner, C., Sparks, A., & Lane, D. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Mol. Cell Biol. 19, 3704-3713 (1999).
20. Lin, W. C., Lin, F. T. & Nevins, J. R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15, 1833-1844 (2001).
21. Durocher, D. & Jackson, S. P. DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? Curr. Opin. Cell Biol. 13, 225-231 (2001).
22. Chehab, N. H., Malikzay, A., Appel, M. & Halazonetis, T. D. Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53. Genes Dev.14, 278-288 (2000).
23. Hirao, A. et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824-1827 (2000).
24. Sheih, S. Y., Ahn, J., Tamai, K., Taya, Y. & Prives, C. The human homologues of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylates p53 at multiple DNA damage-inducible sites. Genes Dev. 14, 289-300 (2000).
25. Falck, J., Maitland, N., Syljuåsen, R. G., Bartek, J. & Lukas, J. The ATM-chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410, 842-847 (2001).
26. Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S. & Piwnica-Worms, H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501-1505 (1997).
27. Lee, J.-S., Collins, K. M., Brown, A. L., Lee, C.-H. & Chung, J. H. HCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404, 201-204 (2000).
28. Yang, S., Kuo, C., Bisi, J. E. & Kim, M. K. PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Nature Cell Biol. 4, 865-870 (2002).
29. Takai, H. et al. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO. J. 21, 5195-5205 (2002).
30. Botz, J. et al. Cell cycle regulation of the murine cyclinE gene depends on an E2F binding site in the promoter. Mol. Cell. Biol. 16, 3401-3409 (1996).
31. Bell, D. W. et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286, 2528-2531 (1999).
32. Falck, J. et al. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway. Oncogene 20, 5505-5510 (2001).
33. Matsuoka, S. et al. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl Acad. Sci. 97, 10389-10394 (2000).
34. Johnson, D. G., Schwartz, J. K., Cress, W. D. & Nevins, J. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365, 349-352 (1993).
35. Johnson, D. G., Cress, W. D., Jakol, L. & Nevins, J. R. Oncogenic capacity of the E2F1 gene. Proc. Natl Acad. Sci. USA. 91, 12823-12827 (1996).
36. Lucas, J., Petersen, B. O., Holm, K., Bartek, J. & Helin, K. Deregulated expression of E2F family members induces S-phase entry and overcome p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16, 1047-1057 (1996).
37. Yamasaki, L. et al. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-) mice. Nature Genet. 18, 360-364 (1998).
38. Lakin, N. D. & Jackson, S. P. Regulation of p53 in response to DNA damage. Oncogene 18, 7644-7655 (1999).
39. Pearson, M. et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406, 207-210 (2000).
40. Koh, L. & Prives, C. P53: puzzle and paradigm. Genes Dev. 10, 1054-1072 (1996).
41. Agami, R. & Bernards, R. Distinct initiation and maintenance mechanisms co-operate to induce G1 cell cycle arrest in response to DNA damage. Cell 102, 55-66 (2000).
42. Allen, K. E., de la Luna, S., Kerkhoven, R. M., Bernards, R. & La Thangue, N. B. Distinct mechanisms of nuclear accumulation regulate the functional consequence of E2F transcription factors. J. Cell Sci. 110, 2819-2831 (1997).
43. Bandara, L. R., Buck, V. M., Zamanian, M., Johnston, L. H. & La Thangue, N. B. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF/E2F. EMBO J. 12, 4317-4324 (1993).
44. Morris, L., Allen, K. E. & La Thangue, N. B. Regulation of E2F transcription by cyclinE/cdk2 kinase mediated through p300/CBP co-activators. Nature Cell Biol. 12, 232-239 (2000).
45. de la Luna, S., Allen, K. E., Mason, S. M. & La Thangue, N. B. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor. EMBO J. 18, 212-228 (1999).
46. Chan, H.-M., Kristic-Demonacos, M., Smith, L., Demonacos, C. & La Thangue, N. B. Acetylation control of the retinoblastoma tumour-suppressor protein. Nature Cell Biol. 3, 667-674 (2001).